FREE CASE EVALUATION: +1-888-885-2771                                          Email us:


J&J, 3M seek ‘basic due diligence’ in MDLs. Get Lawyer.

J&J, 3M Among Companies Seeking 'Basic Due Diligence' In Multidistrict Litigation - More than 30 firms, including Johnson & Johnson and 3M Co, are lobbying the federal judiciary's rulemaking authority to enact a regulation that will allow cases in multidistrict litigation to be culled early on.


In a letter to the Administrative Office of the United States Courts’ committee on rules of practise and procedure, legal officers from 31 companies said they wanted a rule governing MDL management to include a directive to have plaintiffs’ counsel demonstrate ‘basic due diligence into plaintiffs’ claims, such as evidence of exposure to the alleged cause and a resulting injury, early in the case’.

According to the March 1 letter, “high volumes of such unexamined and unsupportable claims are allowed to be ‘parked’ for extended periods of time.”

Kevin Rhodes, executive vice president and chief legal affairs officer at 3M, is one of the letter’s signatories. According to the business, the proposal will “help more efficiently and fairly resolve MDL litigation for claimants with meritorious claims.”

In an MDL, 3M is facing more than 265,000 lawsuits alleging that their Combat Arms military earplugs were defective and caused hearing loss. The firm stated that it believes the plugs were functional and safe when used properly, but that it is seeking to resolve the claims through mediation.

Johnson & Johnson did not reply to a request for comment. The company is facing more than 37,000 cases in an MDL over accusations that its talc products caused cancer. Erik Haas, J&J’s global vice president of litigation, also signed the letter. The corporation insists that its goods are risk-free.

The initiative may face some opposition. According to Ben Whiting, a partner with plaintiffs’ firm Keller Postman, the policy may result in a “rather significant level of proof just to have the right to file.”

The letter was also signed by legal executives from tobacco giant Altria Group Inc, General Motors Co, and Exxon Mobil Corp. Requests for comment were not immediately returned by the companies.

Last year, the court administration’s MDL rules panel created a rough guideline to aid judges managing MDLs in the early phases of the process. If the subcommittee accepts the idea in the letter, it may become part of the regulation.

The subcommittee will convene on March 28 and may opt to refer the proposed rule change to the full rules committee. If adopted by that committee, the regulation might be made available for public comment later this year.

If you or your loved ones suffered cancer after using Talcum Powder. You may be eligible for compensation. Let the hair relaxer expert from the justice now to analyse and evaluate your case at no cost.

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Your Free

Case Evaluation!

The fee is free, you only pay when you win!

Recent News


Sharing is caring.. ?


Get Your compensation now, before it gets too late

The fee is free, you only pay when you win. Get Free Consultation from our expert lawyers.

The Justice Now Legal News

The biggest loser — workers’ compensation?

When you see a person you’ve not seen for several months, You’re probably to ask: “Gee, you look great. Have you lost weight?” The most likely answer is Ozempic Wegovy and Mounjaro. Ozempic, as well as Mounjaro, were designed for treating Type 2 diabetes; Wegovy explicitly intended to be a weight-loss drug, making use of the same semaglutide formulation used in Ozempic.

The Justice Now Legal News

Doctor asks court to toss J&J lawsuit against her over cancer research

A medical scientist has asked the court to dismiss the lawsuit Johnson & Johnson brought against her for her 2019 research on the link between cosmetic talc and cancer. She argued that her work is reliable and is protected by the freedom of speech rights.

The Justice Now Legal News

Appeals court OKs ‘common benefit’ fees in Bard IVC filter litigation. Next stop the Supreme Court?

Appeals court OKs ‘common benefit’ fees in Bard IVC filter litigation. Next stop the Supreme Court? – Lawyers representing plaintiffs who have signed agreements to pay a portion of their fee to chiefs of significant multidistrict litigation have to respect those agreements even if they decide to settle disputes outside the process, as per a federal appeals court ruling that week.

The Justice Now Legal News

Navy, Justice Dept. offer payouts in bid to speed up Camp Lejeune claims

The United States Department of Justice and U.S. Navy announced a program of tier-based payouts to those whom the water contamination on Marine Corps Base Camp Lejeune has harmed.

Ozempic Lawsuit

Ozempic Lawsuit: What you need to know

Ozempic Lawsuit: What you need to know – Ozempic (semaglutide) is an injection of 0.5- 2 mg, an injectable prescribed medicine used by type 2 – diabetic patients to lower the risk of heart attack, stroke, or death. Also, some of them are used for weight loss.

Bard PowerPort Catheter Lawsuit

All You Need to Know About Bard PowerPort Catheter Lawsuit: Latest Updates 2023 and Eligibility Criteria

Bard Powerport Catheter Lawsuit Updates 2023

You might also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

Free Consultation?

Fill out your details and we will get back to you as soon as possible.